87 related articles for article (PubMed ID: 18555904)
21. Methotrexate dose in current ECCO consensus on Crohn's disease.
Karaca C
J Crohns Colitis; 2010 Oct; 4(4):483. PubMed ID: 21122548
[No Abstract] [Full Text] [Related]
22. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
23. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
Sandborn WJ; Tremaine WJ; Lawson GM
Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
[TBL] [Abstract][Full Text] [Related]
24. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
[TBL] [Abstract][Full Text] [Related]
26. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
27. Medical management of Crohn's disease.
Cottone M; Renna S; Orlando A; Mocciaro F
Expert Opin Pharmacother; 2011 Nov; 12(16):2505-25. PubMed ID: 21988215
[TBL] [Abstract][Full Text] [Related]
28. Thalidomide in oral Crohn's disease refractory to conventional medical treatment.
Odeka EB; Miller V
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):250-1. PubMed ID: 9252926
[No Abstract] [Full Text] [Related]
29. [Better to start from top?].
MMW Fortschr Med; 2005 Oct; 147(42):8. PubMed ID: 16281774
[No Abstract] [Full Text] [Related]
30. Medical therapy for refractory pediatric Crohn's disease.
Faubion WA; Bousvaros A
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1199-213. PubMed ID: 16872913
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
Markowitz JF
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
[TBL] [Abstract][Full Text] [Related]
33. [Long term evolution of corticodependant and corticoresistant Crohn's disease patients treated by azzathioprine].
Karoui S; Hamrouni A; Bibani N; Serghini M; Boubaker J; Filali A
Tunis Med; 2011 Jul; 89(7):610-5. PubMed ID: 21780035
[TBL] [Abstract][Full Text] [Related]
34. Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?
Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Papi C
J Gastrointestin Liver Dis; 2012 Mar; 21(1):67-73. PubMed ID: 22457862
[TBL] [Abstract][Full Text] [Related]
35. In favour of early surgery in Crohn's disease: a hypothesis to be tested.
Latella G; Caprilli R; Travis S
J Crohns Colitis; 2011 Feb; 5(1):1-4. PubMed ID: 21272796
[No Abstract] [Full Text] [Related]
36. Thalidomide for Crohn's disease: high dose, low dose, or "no doze" at all?
Katz JA
Inflamm Bowel Dis; 2000 May; 6(2):152-3. PubMed ID: 10833076
[No Abstract] [Full Text] [Related]
37. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
D'Haens GR; Fedorak R; Lémann M; Feagan BG; Kamm MA; Cosnes J; Rutgeerts PJ; Marteau P; Travis S; Schölmerich J; Hanauer S; Sandborn WJ;
Inflamm Bowel Dis; 2009 Oct; 15(10):1599-604. PubMed ID: 19653291
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide for Crohn's disease.
Fishman SJ; Feins NR; D'Amoto RJ; Folkman J
Gastroenterology; 2000 Aug; 119(2):596. PubMed ID: 10960273
[No Abstract] [Full Text] [Related]
39. Thalidomide and refractory Crohn's disease: what is in the future?
Ng SC
J Clin Gastroenterol; 2014 Jul; 48(6):476-7. PubMed ID: 24781387
[No Abstract] [Full Text] [Related]
40. What is in store for your Crohn's patient?
Weitzman G; Maltz C
J Clin Gastroenterol; 2006 Feb; 40(2):93-5. PubMed ID: 16394867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
